Printer Friendly
The Free Library
19,585,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Abraxis BioScience Launches Ondansetron Injection, USP.


LOS ANGELES -- Abraxis BioScience, Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
: ABBI Advanced Breast Biopsy Instrument (ABBI)
Uses a rotating circular knife and thin heated electrical wire to remove a large cylinder of abnormal breast tissue.

Mentioned in: Fibrocystic Condition of the Breast
), an integrated, global biopharmaceutical company, today announced that it has launched Ondansetron Injection, USP USP - unique sales point , the generic equivalent of GlaxoSmithKline's Zofran([R]) Injection. According to IMS, sales in 2005 of ondansetron in the United States exceeded $587 million. The company markets ondansetron in AP-rated single-dose and multiple-dose bar coded, latex-free vials.

Ondansetron Injection is indicated for the prevention of nausea and vomiting Nausea and Vomiting Definition

Nausea is the sensation of being about to vomit. Vomiting, or emesis, is the expelling of undigested food through the mouth.
 associated with initial and repeat courses of emetogenic cancer chemotherapy, including high-dose cisplatin, and prevention of postoperative nausea and/or vomiting.

About Abraxis BioScience, Inc.

Abraxis BioScience, Inc. is an integrated global biopharmaceutical company dedicated to meeting the needs of critically ill patients. The company develops, manufactures and markets one of the broadest portfolios of injectable products and leverages revolutionary technology such as its nab[TM] platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life-threatening diseases. The first FDA approved product to use this nab platform, ABRAXANE([R]), was launched in 2005 for the treatment of metastatic breast cancer. Abraxis trades on the NASDAQ Stock Market Nasdaq stock market

The first electronic stock market listing over 5000 companies. The Nasdaq stock market comprises two separate markets, namely the Nasdaq National Market, which trades large, active securities and the Nasdaq Smallcap Market that trades emerging growth companies.
 under the symbol ABBI. For more information about the company and its products, please visit www.abraxisbio.com.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jan 4, 2007
Words:199
Previous Article:Atlantic Pacific Bank Launches 'DeskTeller' Remote Deposit Technology.
Next Article:Phase Bioscience Announces Investment from Johnson & Johnson Development Corporation.
Topics:



Related Articles
Nausea drug may aid alcoholism treatment.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles